25-year follow-up after lung transplantation at Lund University Hospital in Sweden: superior results obtained for patients with cystic fibrosis
CONCLUSIONS
Superior long-term survival rates were seen in recipients diagnosed with cystic fibrosis, α1-antitrypsin deficiency and pulmonary hypertension. DLTx showed better results compared with SLTx especially at 10 years post-transplant. In the present study, we present cumulative incidence rates of bronchiolitis obliterans syndrome of 15% at 5 years, 26% at 10 years and 32% at 20 years post-transplant; these figures are in line with the lowest rates presented internationally.
Source: Interactive CardioVascular and Thoracic Surgery - Category: Cardiovascular & Thoracic Surgery Authors: Fakhro, M., Ingemansson, R., Skog, I., Algotsson, L., Hansson, L., Koul, B., Gustafsson, R., Wierup, P., Lindstedt, S. Tags: Trachea and bronchi Thoracic Source Type: research
More News: Alpha-1 Antitrypsin Deficiency | Bronchiolitis | Cardiology | Cardiovascular | Cardiovascular & Thoracic Surgery | Cystic Fibrosis | Health | Health Insurance | Heart | Heart Transplant | Hypertension | Insurance | Lung Transplant | Pulmonary Hypertension | Study | Transplant Surgery | Transplants